Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2–4)

Efficacy and safety of tiotropium+olodaterol fixed-dose combination (FDC) compared with the mono-components was evaluated in patients with moderate to very severe chronic obstructive pulmonary disease (COPD) in two replicate, randomised, double-blind, parallel-group, multicentre, phase III trials. P...

Descripción completa

Detalles Bibliográficos
Autores principales: Buhl, Roland, Maltais, François, Abrahams, Roger, Bjermer, Leif, Derom, Eric, Ferguson, Gary, Fležar, Matjaž, Hébert, Jacques, McGarvey, Lorcan, Pizzichini, Emilio, Reid, Jim, Veale, Antony, Grönke, Lars, Hamilton, Alan, Korducki, Lawrence, Tetzlaff, Kay, Waitere-Wijker, Stella, Watz, Henrik, Bateman, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391658/
https://www.ncbi.nlm.nih.gov/pubmed/25573406
http://dx.doi.org/10.1183/09031936.00136014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391658/
https://www.ncbi.nlm.nih.gov/pubmed/25573406
http://dx.doi.org/10.1183/09031936.00136014

Ejemplares similares